Adamant Biomedical Investments AG current holdings: Foreign ADRs
Adamant Biomedical Investments AG reported $0.01 billion in depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), 2 positions, in its Form 13F for the quarter ended 2014-12-31; the largest are WUXI PHARMATECH INC, SHIRE PLC.
- WUXI PHARMATECH INC: Country of operation —; Class SPONS ADR SHS; Shares 140,000; Value $4,714,000.
- SHIRE PLC: Country of operation —; Class SPONSORED ADR; Shares 11,000; Value $2,338,000.
Form 13F-HR as filed (SEC CIK 1542336): quarter ended 2014-12-31, filed 2015-02-13. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Not available yet | |||